Evidence map›Paper›PMID 37030453›Full record

ArticleOphthalmology2023

Epidemiologic Evaluation of Retinopathy of Prematurity Severity in a Large Telemedicine Program in India Using Artificial Intelligence.

Mallory A deCampos-Stairiker, Aaron S Coyner, Aditi Gupta, Minn Oh, Parag K Shah, Prema Subramanian, Narendran Venkatapathy, Praveer Singh, Jayashree Kalpathy-Cramer, Michael F Chiang and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. [Research progress in artificial intelligence for the diagnosis and management of diseases in preterm infants].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Mallory A deCampos-StairikerOphthalmology, Oregon Health & Science University, Portland, Oregon.
Aaron S CoynerOphthalmology, Oregon Health & Science University, Portland, Oregon.
Aditi GuptaOphthalmology, Oregon Health & Science University, Portland, Oregon.
Minn OhOphthalmology, Oregon Health & Science University, Portland, Oregon.
Parag K ShahPediatric Retina and Ocular Oncology, Aravind Eye Hospital, Coimbatore, India.
Prema SubramanianPediatric Retina and Ocular Oncology, Aravind Eye Hospital, Coimbatore, India.
Narendran VenkatapathyPediatric Retina and Ocular Oncology, Aravind Eye Hospital, Coimbatore, India.
Praveer SinghOphthalmology, University of Colorado, Aurora, Colorado; Radiology, MGH/Harvard Medical School, Charlestown, Massachusetts.
Jayashree Kalpathy-CramerOphthalmology, University of Colorado, Aurora, Colorado; Radiology, MGH/Harvard Medical School, Charlestown, Massachusetts.
Michael F ChiangNational Eye Institute, National Institute of Health, Bethesda, Maryland; National Library of Medicine, National Institute of Health, Bethesda, Maryland.
R V Paul ChanIllinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois.
J Peter CampbellOphthalmology, Oregon Health & Science University, Portland, Oregon. Electronic address: campbelp@ohsu.edu.
Oregon Health & Science University · USAravind Eye Hospital · INUniversity of Colorado Hospital · USNew York Eye and Ear Infirmary · USUnited States National Library of Medicine · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TED S ACOTT · 1995 to 2026
$19.4M
Clinical and Genetic Analysis of Retinopathy of PrematurityR01EY019474 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2010 to 2020
$7.0M
Artificial Intelligence Assisted Panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01HD107494 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell, Yifan Jian · 2021 to 2026
$2.4M
Clinical and genetic analysis of retinopathy of prematurityR01HD107493 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER · 2021 to 2023
$1.8M
Robust AI to develop risk models in retinopathy of prematurity using deep learningR21EY031883 · NEI · MASSACHUSETTS GENERAL HOSPITAL · PI KALPATHY-CRAMER, JAYASHREE, RUBIN, DANIEL L · 2020 to 2021
$472k
Artificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01EY031331 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER, JIAN, YIFAN · 2020 to 2020
$342k
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY019474NEI NIH HHS R01 EY031331NEI NIH HHS R21 EY031883NICHD NIH HHS R01 HD107493NICHD NIH HHS R01 HD107494
6 · The paper itself

Abstract

purposeEpidemiological changes in retinopathy of prematurity (ROP) depend on neonatal care, neonatal mortality, and the ability to carefully titrate and monitor oxygen. We evaluate whether an artificial intelligence (AI) algorithm for assessing ROP severity in babies can be used to evaluate changes in disease epidemiology in babies from South India over a 5-year period.

designRetrospective cohort study.

participantsBabies (3093) screened for ROP at neonatal care units (NCUs) across the Aravind Eye Care System (AECS) in South India.

methodsImages and clinical data were collected as part of routine tele-ROP screening at the AECS in India over 2 time periods: August 2015 to October 2017 and March 2019 to December 2020. All babies in the original cohort were matched 1:3 by birthweight (BW) and gestational age (GA) with babies in the later cohort. We compared the proportion of eyes with moderate (type 2) or treatment-requiring (TR) ROP, and an AI-derived ROP vascular severity score (from retinal fundus images) at the initial tele-retinal screening exam for all babies in a district, VSS), in the 2 time periods.

main outcome measuresDifferences in the proportions of type 2 or worse and TR-ROP cases, and VSS between time periods.

resultsAmong BW and GA matched babies, the proportion [95% confidence interval {CI}] of babies with type 2 or worse and TR-ROP decreased from 60.9% [53.8%-67.7%] to 17.1% [14.0%-20.5%] (P < 0.001) and 16.8% [11.9%-22.7%] to 5.1% [3.4%-7.3%] (P < 0.001), over the 2 time periods. Similarly, the median [interquartile range] VSS in the population decreased from 2.9 [1.2] to 2.4 [1.8] (P < 0.001).

conclusionsIn South India, over a 5-year period, the proportion of babies developing moderate to severe ROP has dropped significantly for babies at similar demographic risk, strongly suggesting improvements in primary prevention of ROP. These results suggest that AI-based assessment of ROP severity may be a useful epidemiologic tool to evaluate temporal changes in ROP epidemiology. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.

Indexed as

Retinopathy of PrematurityTelemedicineArtificial IntelligenceBirth WeightGestational AgeHumansInfantInfant, NewbornNeonatal ScreeningRetrospective StudiesRisk FactorsArtificial intelligenceEpidemiologyLongitudinal analysisRetinopathy of prematurityTelemedicine

Identifiers

PMID37030453
PMCPMC10524227
OpenAlexW4362673513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.